People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rezo Therapeutics, Inc. | — | Biotechnology | Series C | $46.3M | $868.3M | 2022 |
Sourav Bandyopadhyay at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sourav Bandyopadhyay on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tiba Aynechi | 1 | 9 |
| Simeon George | 1 | 8 |
| Vineeta Agarwala | 1 | 8 |
| George Scangos | 1 | 4 |
| Norbert Bischofberger | 1 | 2 |
| Nadir Mahmood | 1 | 1 |
| Derek Hicks | 1 | 1 |
| Nevan Krogan | 1 | 1 |
| Jennifer Chang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.